首页> 美国卫生研究院文献>American Journal of Stem Cells >Stepping back to move forward: a current review of iPSCs in the fight against Alzheimer’s disease
【2h】

Stepping back to move forward: a current review of iPSCs in the fight against Alzheimer’s disease

机译:退后一步:抗击阿尔茨海默氏病的iPSC的最新评论

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The successful generation of the first iPSCs about ten years ago has provided deeper insight into previously unknown disease mechanisms and therapeutic opportunities for many diseases. In particular, iPSCs are becoming an important tool in advancing modeling and therapeutic intervention for Alzheimer’s disease. In this manuscript, we assess the research climate surrounding the application of iPSCs to familial and sporadic Alzheimer’s disease, including the generation and isolation of individualized neural stem cells, the introduction of neural stem cell transplants using iPSCs, and an estimation of the potential use of iPSCs as research models for Alzheimer’s treatments and therapies. The clinical application of stem cells in the treatment of Alzheimer’s disease appears promising, but much of the recent experimentation has been conducted using animal models or embryonic stem cells. As induced pluripotent stem cell research advances, iPSCs will likely provide investigators with a more applicable tool to progress advances in research and treatment for Alzheimer’s and other neurodegenerative diseases.
机译:大约十年前成功生产出了第一批iPSC,这使人们对以前未知的疾病机制和许多疾病的治疗机会有了更深入的了解。特别是,iPSC正在成为促进阿尔茨海默氏病建模和治疗干预的重要工具。在本手稿中,我们评估了围绕iPSC在家族性和散发性阿尔茨海默氏病中应用的研究环境,包括个体化神经干细胞的产生和分离,使用iPSC引入神经干细胞移植,以及对iPSC潜在用途的估计。 iPSC作为阿尔茨海默氏病治疗方法的研究模型。干细胞在治疗阿尔茨海默氏病中的临床应用似乎很有希望,但是最近的许多实验都是使用动物模型或胚胎干细胞进行的。随着诱导性多能干细胞研究的发展,iPSC可能会为研究人员提供更适用的工具,以促进阿尔茨海默氏病和其他神经退行性疾病研究和治疗的进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号